Dr Reddy's launches generic version of Rapamune tablets in US

NEW DELHI: Dr Reddy's Laboratories today said it has launched a generic version of Wyeth's Rapamune tablets, an immunosuppressant, in the US market.

The company has launched Sirolimus tablets, a therapeutic equivalent generic version of Rapamune tablets in the US market following the approval of US Food and Drug Administration ( USFDA), Dr Reddy's Laboratories Ltd said in a filing to the BSE.

According to IMS Health sales data, the Rapamune brand had sales of $206 million in the US market for 12 months ended August 2014, it added.

The Hyderabad-based firm's Sirolimus tablets in 1 and 2 mg strengths are available in bottle counts of 100, the company said.

Dr Reddy's scrip closed at Rs 3,080.65, down 0.80 per cent, on the BSE.